Abstract
This study of 845 patients with type 2 diabetes was conducted in 12 primary care general practices in a geographically cohesive region in Germany. It showed that about a fifth of these patients with known diabetes had a HbA1c of 8% or over, and therefore are in need of better glycaemic control. Younger patients seem to be at special risk for high HbA1c values, and they should receive particular attention with respect to preventive measures for better glycaemic treatment.
Full Text
The Full Text of this article is available as a PDF (62.2 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gray A., Raikou M., McGuire A., Fenn P., Stevens R., Cull C., Stratton I., Adler A., Holman R., Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). United Kingdom Prospective Diabetes Study Group. BMJ. 2000 May 20;320(7246):1373–1378. doi: 10.1136/bmj.320.7246.1373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Herman W. H., Aubert R. E., Engelgau M. M., Thompson T. J., Ali M. A., Sous E. S., Hegazy M., Badran A., Kenny S. J., Gunter E. W. Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med. 1998 Dec;15(12):1045–1051. doi: 10.1002/(SICI)1096-9136(1998120)15:12<1045::AID-DIA696>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
- King H., Aubert R. E., Herman W. H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998 Sep;21(9):1414–1431. doi: 10.2337/diacare.21.9.1414. [DOI] [PubMed] [Google Scholar]
- Nathan D. M., Singer D. E., Hurxthal K., Goodson J. D. The clinical information value of the glycosylated hemoglobin assay. N Engl J Med. 1984 Feb 9;310(6):341–346. doi: 10.1056/NEJM198402093100602. [DOI] [PubMed] [Google Scholar]